5 Einträge gefunden

1. Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

   1. Höflmayer, Doris
   2. Steinhoff, Amélie
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Burandt, Eike
   7. Tsourlakis, Maria Christina

   2020 - Forschungsinformationssystem des UKE
2. Upregulation of PTTG1 is associated with poor prognosis in prostate cancer

   1. Fraune, Christoph
   2. Yehorov, Serhiy
   3. Luebke, Andreas M
   4. Steurer, Stefan
   5. Hube-Magg, Claudia
   6. Büscheck, Franziska
   7. Höflmayer, Doris

   2020 - Forschungsinformationssystem des UKE
3. Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

   1. Luebke, Andreas M
   2. Attarchi-Tehrani, Ali
   3. Meiners, Jan
   4. Hube-Magg, Claudia
   5. Lang, Dagmar S
   6. Kluth, Martina
   7. Tsourlakis, Maria Christina

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
4. Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

   1. Minner, Sarah
   2. Lutz, Jannes
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Höflmayer, Doris
   7. Burandt, Eike

   2019 - Forschungsinformationssystem des UKE
5. Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion

   1. Steurer, Stefan
   2. Schwemmer, Lara
   3. Hube-Magg, Claudia
   4. Büscheck, Franziska
   5. Höflmayer, Doris
   6. Tsourlakis, Maria Christina
   7. Clauditz, Till S

   2019 - Forschungsinformationssystem des UKE